Clinical Trials Logo

Recurrent/Metastatic Breast Cancer clinical trials

View clinical trials related to Recurrent/Metastatic Breast Cancer.

Filter by:
  • None
  • Page 1

NCT ID: NCT01840293 Recruiting - Clinical trials for Primary Breast Cancer

Breast Cancer Proteomics and Molecular Heterogeneity

Start date: February 2013
Phase: N/A
Study type: Observational

Primary objective: The primary objective is to define the proteomic and molecular characteristics of primary and recurrent/ metastatic breast tumours with special focus on the expression of S100 protein and the estrogen receptor (ER), progesterone receptor (PR) and epidermal growth factor receptor 2 (HER2) genes Secondary objective: - To expand our understanding of the complex molecular pathways dictating the progression of breast cancer and their response to different treatment regimes. - To relate proteomic findings to survival data - To identify potential serum markers of breast cancer progression